These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35965838)

  • 1. Autoantibodies against NMDAR subunit NR1 disappear from blood upon anesthesia.
    Teller J; Jung C; Wilke JBH; Schimmelpfennig SD; Hindermann M; Hinken L; Gabriel MM; Fegbeutel C; Schäfer A; Laser H; Lichtinghagen R; Worthmann H; Weissenborn K; Ehrenreich H
    Brain Behav Immun Health; 2022 Oct; 24():100494. PubMed ID: 35965838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
    Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
    Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against the
    Ehrenreich H
    Front Immunol; 2017; 8():181. PubMed ID: 28298911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
    Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
    Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
    Ehrenreich H
    Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
    Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
    Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
    Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
    Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
    Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
    Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
    Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
    Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.
    Wilke JBH; Hindermann M; Berghoff SA; Zihsler S; Arinrad S; Ronnenberg A; Barnkothe N; Steixner-Kumar AA; Röglin S; Stöcker W; Hollmann M; Nave KA; Lühder F; Ehrenreich H
    Mol Psychiatry; 2021 Dec; 26(12):7746-7759. PubMed ID: 34331009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance.
    Arinrad S; Wilke JBH; Seelbach A; Doeren J; Hindermann M; Butt UJ; Steixner-Kumar AA; Spieth L; Ronnenberg A; Pan H; Berghoff SA; Hollmann M; Lühder F; Nave KA; Bechter K; Ehrenreich H
    Mol Psychiatry; 2022 Dec; 27(12):4974-4983. PubMed ID: 34866134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
    Hammer C; Stepniak B; Schneider A; Papiol S; Tantra M; Begemann M; Sirén AL; Pardo LA; Sperling S; Mohd Jofrry S; Gurvich A; Jensen N; Ostmeier K; Lühder F; Probst C; Martens H; Gillis M; Saher G; Assogna F; Spalletta G; Stöcker W; Schulz TF; Nave KA; Ehrenreich H
    Mol Psychiatry; 2014 Oct; 19(10):1143-9. PubMed ID: 23999527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of autoantibodies against brain antigens in health and disease.
    Dahm L; Ott C; Steiner J; Stepniak B; Teegen B; Saschenbrecker S; Hammer C; Borowski K; Begemann M; Lemke S; Rentzsch K; Probst C; Martens H; Wienands J; Spalletta G; Weissenborn K; Stöcker W; Ehrenreich H
    Ann Neurol; 2014 Jul; 76(1):82-94. PubMed ID: 24853231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects.
    Daguano Gastaldi V; Bh Wilke J; Weidinger CA; Walter C; Barnkothe N; Teegen B; Luessi F; Stöcker W; Lühder F; Begemann M; Zipp F; Nave KA; Ehrenreich H
    Brain Behav Immun; 2023 Feb; 108():135-147. PubMed ID: 36323361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial stress, blood brain barrier and the development of anti N-methyl-D-aspartate receptor (NMDAR) encephalitis.
    Vahabi Z; Etesam F; Zandifar A; Badrfam R
    Mult Scler Relat Disord; 2021 May; 50():102876. PubMed ID: 33690087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
    Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
    PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive and Therapeutic Autoantibodies Protect against Neuronal Excitotoxicity.
    Zhou X
    J Psychiatr Brain Sci; 2023; 8(3):. PubMed ID: 37502631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression, purification and immunoreactivity characterization of extracellular antigenic domains of NMDAR1 protein].
    Bao D; Li W; Shi L; Li Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Dec; 33(12):1979-1988. PubMed ID: 29271175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function.
    Jurek B; Chayka M; Kreye J; Lang K; Kraus L; Fidzinski P; Kornau HC; Dao LM; Wenke NK; Long M; Rivalan M; Winter Y; Leubner J; Herken J; Mayer S; Mueller S; Boehm-Sturm P; Dirnagl U; Schmitz D; Kölch M; Prüss H
    Ann Neurol; 2019 Nov; 86(5):656-670. PubMed ID: 31325344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in expression of N-methyl-D-aspartate receptor subunits in the rat neostriatum after a single dose of antisense oligonucleotide specific for N-methyl-D-aspartate receptor 1 subunit.
    Lai SK; Wong CK; Yang MS; Yung KK
    Neuroscience; 2000; 98(3):493-500. PubMed ID: 10869843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.